New drug therapy could improve brain function and life expectancy of ALS patients
Ben-Gurion University of the Negev (BGU) researchers are developing a new therapy for Amyotrophic Lateral Sclerosis (ALS) using part of an existing FDA-approved drug that restores the central nervous system's (CNS) immune ...
May 25, 2017
0
1